183 related articles for article (PubMed ID: 28737621)
1. Baroreflex activation therapy: a new approach to the management of advanced heart failure with reduced ejection fraction.
Gronda E; Francis D; Zannad F; Hamm C; Brugada J; Vanoli E
J Cardiovasc Med (Hagerstown); 2017 Sep; 18(9):641-649. PubMed ID: 28737621
[TBL] [Abstract][Full Text] [Related]
2. Interventional and device-based autonomic modulation in heart failure.
Shen MJ; Zipes DP
Heart Fail Clin; 2015 Apr; 11(2):337-48. PubMed ID: 25834979
[TBL] [Abstract][Full Text] [Related]
3. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.
Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J
Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103
[TBL] [Abstract][Full Text] [Related]
4. Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.
Gronda E; Vanoli E
Curr Heart Fail Rep; 2016 Dec; 13(6):273-280. PubMed ID: 27854009
[TBL] [Abstract][Full Text] [Related]
5. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
6. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
[TBL] [Abstract][Full Text] [Related]
7. Non-pharmacological modulation of the autonomic tone to treat heart failure.
Singh JP; Kandala J; Camm AJ
Eur Heart J; 2014 Jan; 35(2):77-85. PubMed ID: 24174128
[TBL] [Abstract][Full Text] [Related]
8. Deep and future insights into neuromodulation therapies for heart failure.
Kishi T
J Cardiol; 2016 Nov; 68(5):368-372. PubMed ID: 27293020
[TBL] [Abstract][Full Text] [Related]
9. Autonomic Modulation in Heart Failure: Ready for Prime Time?
Dunlap ME; Bhardwaj A; Hauptman PJ
Curr Cardiol Rep; 2015 Nov; 17(11):103. PubMed ID: 26384110
[TBL] [Abstract][Full Text] [Related]
10. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
[TBL] [Abstract][Full Text] [Related]
11. [The neurovegetative system in heart failure and heart transplantation].
Mortara A
Ital Heart J Suppl; 2001 Aug; 2(8):871-87. PubMed ID: 11582720
[TBL] [Abstract][Full Text] [Related]
12. Central command: control of cardiac sympathetic and vagal efferent nerve activity and the arterial baroreflex during spontaneous motor behaviour in animals.
Matsukawa K
Exp Physiol; 2012 Jan; 97(1):20-8. PubMed ID: 21984731
[TBL] [Abstract][Full Text] [Related]
13. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
[TBL] [Abstract][Full Text] [Related]
14. Autonomic regulation therapy suppresses quantitative T-wave alternans and improves baroreflex sensitivity in patients with heart failure enrolled in the ANTHEM-HF study.
Libbus I; Nearing BD; Amurthur B; KenKnight BH; Verrier RL
Heart Rhythm; 2016 Mar; 13(3):721-8. PubMed ID: 26601770
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.
Zucker IH; Liu JL
Heart Fail Rev; 2000 Mar; 5(1):27-43. PubMed ID: 16228914
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle electrical stimulation improves baroreflex sensitivity and heart rate variability in heart failure rats.
Lazzarotto Rucatti A; Jaenisch RB; Rossato DD; Bonetto JH; Ferreira J; Xavier LL; Sonza A; Dal Lago P
Auton Neurosci; 2015 Dec; 193():92-6. PubMed ID: 26433753
[TBL] [Abstract][Full Text] [Related]
17. Vagal stimulation in heart failure.
De Ferrari GM
J Cardiovasc Transl Res; 2014 Apr; 7(3):310-20. PubMed ID: 24500409
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure.
Gronda E; Brambilla G; Seravalle G; Maloberti A; Cairo M; Costantino G; Lovett E; Vanoli E; Mancia G; Grassi G
Clin Res Cardiol; 2016 Oct; 105(10):838-46. PubMed ID: 27120329
[TBL] [Abstract][Full Text] [Related]
19. Device therapy to modulate the autonomic nervous system to treat heart failure.
Lopshire JC; Zipes DP
Curr Cardiol Rep; 2012 Oct; 14(5):593-600. PubMed ID: 22833301
[TBL] [Abstract][Full Text] [Related]
20. Baroreflex Activation Therapy in Heart Failure With Reduced Ejection Fraction: Available Data and Future Perspective.
Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
Curr Heart Fail Rep; 2016 Apr; 13(2):71-6. PubMed ID: 26879389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
